StonvexLoading…
StonvexStonvexStonvexCore line items from CODX's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $622.49K | $3.92M | $6.81M | $34.22M |
Operating Income | $-50.17M | $-40.08M | $-42.71M | $-26.98M |
Net Income | $-46.90M | $-37.64M | $-35.33M | $-14.24M |
EPS (Diluted) | $-35.25 | $-37.22 | $-1.20 | $-0.45 |
Total Assets | $24.74M | $63.56M | $95.32M | $123.09M |
Total Liabilities | $4.11M | $9.69M | $9.31M | $8.57M |
Cash & Equivalents | $11.88M | $2.94M | $14.92M | $22.97M |
Free Cash Flow OCF − CapEx | $-29.84M | $-29.90M | $-23.45M | $5.14M |
Shares Outstanding | 2.10M | 1.10M | 31.26M | 30.87M |